Market Movers: Legend (LEGN) Jumps 6.97% to Close at $51.10 June 23

Equities Staff  |

Shares of Legend Biotech Corp - ADR (NASDAQ:LEGN) traded 6.97% up on June 23 to close at $51.10.

733,572 traded hands. Their current average 30 day volume is 599,591 shares.

Legend is up 2.49% year-to-date in 2022.

The company anticipates its next earnings on 2022-08-23.

For technical charts, analysis, and more on Legend visit the company profile.

About Legend Biotech Corp - ADR

Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The team of over 800 employees across the United States, China and Europe, along with its differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture cutting edge cell therapies for patients in need.

To get more information on Legend Biotech Corp - ADR and to follow the company's latest updates, you can visit the company's profile page here: Legend Biotech Corp - ADR's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content